News

October 10, 2016October 10, 2016

Clinical Trial Reveals Additional ResApp Results in Diagnosing Asthma, Pneumonia, URTI, COPD

Asthma, COPD, News, Pneumonia

ResApp Health announced additional positive results from its clinical study evaluating ResApp’s technology in adults with chronic obstructive respiratory disease (COPD), asthma, pneumonia, and upper respiratory tract infection (URTI). ResApp is ... Read more

October 7, 2016October 7, 2016

NICE Acts to Make Tagrisso Available to Patients in UK with Agressive Lung Cancer

Lung Cancer, News

The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Tagrisso (osimertinib) be made available within the National Health Service (NHS) in England and Wales to treat a particularly aggressive form ... Read more

October 6, 2016October 6, 2016

Digital App Ensures Adequate Nutrition and Care for Cystic Fibrosis Patients

Cystic Fibrosis, News

Many people with cystic fibrosis (CF) need help to ensure they’re getting adequate nutrition and the correct amount of enzymes, as well as related reminders. As part of the European MyCyFAPP project, researchers are ... Read more

October 4, 2016October 4, 2016

How Compound in Grapes and Wine Prevents Bacteria-Triggered Airway Inflammation Identified

Asthma, COPD, News

How a natural compound — resveratrol, found in grapes and red wine — works to reduce the inflammation caused by a bacterial infection that is particularly worrisome in people with airway disorders, such as asthma and ... Read more

October 3, 2016October 3, 2016

American Lung Association ‘Freedom from Smoking’ Videos to Air at 25,000 Clinics

Asthma, COPD, Lung Cancer, News

ContextMedia:Health and the American Lung Association (ALA) partnered to deliver lung health information through original video content, presenting the “Freedom from Smoking” online cessation program. ContextMedia:Health is a provider of digital solutions at ... Read more

September 29, 2016September 29, 2016

Three-fold Risk of Asthma Attacks Seen in Patients Most Exposed to Volcanic Eruptions in Hawai

Asthma, News

People with asthma, especially children, who are exposed to high levels of sulfur dioxide (SO2) in gases released from the active volcano Kīlauea, in Hawai, are at greater risk of having ... Read more

September 28, 2016September 28, 2016

Specific Mold Toxins Weaken Airways’ Defenses and Immunity, Penn Study Shows

COPD, Cystic Fibrosis, News

Researchers at the Perelman School of Medicine at the University of Pennsylvania found that toxins from a type of mold, called aflatoxins, weaken the airways’ self-clearing mechanisms and immunity, which may ... Read more

September 27, 2016September 27, 2016

UCLA Researchers Develop 3D ‘Lung Organoids’ as New Tool to Study Lung Diseases

Idiopathic Pulmonary Fibrosis, News

By converting adult lung cells to stem cells, a team of UCLA researchers developed mini-lungs in a culture dish, called lung organoids. This 3D lung tissue can be used to study ... Read more

September 26, 2016September 26, 2016

Inventiva Receives €2.3 Million to Support YAP/TEAD Protein Research Program

Lung Cancer, News

Inventiva has been awarded two grants totaling €2.3 million ($2.58 million) to further its YAP/TEAD protein research program, which focuses on developing molecules with the potential to treat severe forms of lung, ... Read more

September 23, 2016September 23, 2016

Genentech’s Tecentriq Seen to Significantly Increase Survival in Patients with Specific Type of Lung Cancer

Lung Cancer, News

Genentech recently announced positive results for its cancer immunotherapy Tecentriq (atezolizumab) being tested in the Phase 3 clinical trial OAK (NCT02008227). Tecentriq is a monoclonal antibody designed to bind to an immune checkpoint protein ... Read more